[
  {
    "ts": "2025-11-06T11:00:25+00:00",
    "headline": "If EPS Growth Is Important To You, Boston Scientific (NYSE:BSX) Presents An Opportunity",
    "summary": "It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...",
    "url": "https://finance.yahoo.com/news/eps-growth-important-boston-scientific-110025982.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "263e0707-6da1-3e37-a497-d84d1d09280a",
      "content": {
        "id": "263e0707-6da1-3e37-a497-d84d1d09280a",
        "contentType": "STORY",
        "title": "If EPS Growth Is Important To You, Boston Scientific (NYSE:BSX) Presents An Opportunity",
        "description": "",
        "summary": "It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...",
        "pubDate": "2025-11-06T11:00:25Z",
        "displayTime": "2025-11-06T11:00:25Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/f07ef6f3ab742340c5e8f39cd1ee19ab",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sFax.1EIpS7VVYvaDN0jRw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/f07ef6f3ab742340c5e8f39cd1ee19ab.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OB69YGFZw788CGHTsahrkQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/f07ef6f3ab742340c5e8f39cd1ee19ab.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/eps-growth-important-boston-scientific-110025982.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eps-growth-important-boston-scientific-110025982.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-06T13:09:00+00:00",
    "headline": "Boston Scientific (BSX): Evaluating Valuation After Strong Q3 Results and New Product Launches",
    "summary": "Boston Scientific (BSX) is in the spotlight after reporting third-quarter financial results that show strong sales growth and operational execution. The company has also expanded its medical device offerings in Peripheral Interventions and Cardiology. See our latest analysis for Boston Scientific. Boston Scientific’s recent momentum in sales and product innovation has kept investors optimistic, helping push the stock to a year-to-date share price return of 10.65%. With a 14.41% total...",
    "url": "https://finance.yahoo.com/news/boston-scientific-bsx-evaluating-valuation-130900015.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "7f741b02-a544-36f9-a105-cd780a2cf230",
      "content": {
        "id": "7f741b02-a544-36f9-a105-cd780a2cf230",
        "contentType": "STORY",
        "title": "Boston Scientific (BSX): Evaluating Valuation After Strong Q3 Results and New Product Launches",
        "description": "",
        "summary": "Boston Scientific (BSX) is in the spotlight after reporting third-quarter financial results that show strong sales growth and operational execution. The company has also expanded its medical device offerings in Peripheral Interventions and Cardiology. See our latest analysis for Boston Scientific. Boston Scientific’s recent momentum in sales and product innovation has kept investors optimistic, helping push the stock to a year-to-date share price return of 10.65%. With a 14.41% total...",
        "pubDate": "2025-11-06T13:09:00Z",
        "displayTime": "2025-11-06T13:09:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/f07ef6f3ab742340c5e8f39cd1ee19ab",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sFax.1EIpS7VVYvaDN0jRw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/f07ef6f3ab742340c5e8f39cd1ee19ab.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OB69YGFZw788CGHTsahrkQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/f07ef6f3ab742340c5e8f39cd1ee19ab.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-bsx-evaluating-valuation-130900015.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-bsx-evaluating-valuation-130900015.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]